Mohammed Selman

451 Smyth Rd
Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancer.

Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancer.

Journal: Molecular therapy. Oncology

Published: July 19, 2023

Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome.

Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome.

Journal: Journal of virology

Published: April 18, 2023

The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.

The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.

Journal: Communications biology

Published: September 05, 2019

Enhancement of oncolytic virotherapy by vanadium(V) dipicolinates.

Enhancement of oncolytic virotherapy by vanadium(V) dipicolinates.

Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine

Published: May 07, 2019

Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.

Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.

Journal: Science translational medicine

Published: August 21, 2017

Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.

Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 23, 2017

Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.

Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.

Journal: International journal of cancer

Published: May 03, 2017

Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity.

Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity.

Journal: Molecular therapy oncolytics

Published: December 21, 2015

First-in-class small molecule potentiators of cancer virotherapy.

First-in-class small molecule potentiators of cancer virotherapy.

Journal: Scientific reports

Published: September 09, 2015

The genome of an Encephalitozoon cuniculi type III strain reveals insights into the genetic diversity and mode of reproduction of a ubiquitous vertebrate pathogen.

The genome of an Encephalitozoon cuniculi type III strain reveals insights into the genetic diversity and mode of reproduction of a ubiquitous vertebrate pathogen.

Journal: Heredity

Published: September 08, 2015

Genome analyses suggest the presence of polyploidy and recent human-driven expansions in eight global populations of the honeybee pathogen Nosema ceranae.

Genome analyses suggest the presence of polyploidy and recent human-driven expansions in eight global populations of the honeybee pathogen Nosema ceranae.

Journal: Environmental microbiology

Published: March 03, 2015

Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30.

Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30.

Journal: Virology journal

Published: May 01, 2013

Showing 1-12 of 20

Last Updated: 09/26/2026